Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William L Read

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Scientific Reports|September 4, 2020
Dose-response assessment by quantitative MRI in a phase 1 clinical study of the anti-cancer vascular disrupting agent crolibulinAndres M Arias Lorza, Harshan Ravi, Rohit C Philip, et al.
Cancer|November 24, 2020
A randomized, open-label, phase 2, multicenter trial of gemcitabine with pazopanib or gemcitabine with docetaxel in patients with advanced soft-tissue sarcomaNeeta Somaiah, Brian Andrew Van Tine, Amy E Wahlquist, et al.
Neuro-Oncology|April 4, 2017
Timed sequential therapy of the selective T-type calcium channel blocker mibefradil and temozolomide in patients with recurrent high-grade gliomasMatthias Holdhoff, Xiaobu Ye, Jeffrey G Supko, et al.
Neuro-Oncology|August 8, 2018
Response assessment of meningioma: 1D, 2D, and volumetric criteria for treatment response and tumor progressionRaymond Y Huang, Prashin Unadkat, Wenya Linda Bi, et al.
European Journal of Cancer (Oxford, England : 1990)|October 10, 2022
A randomised phase II trial of a trivalent ganglioside vaccine targeting GM2, GD2 and GD3 combined with immunological adjuvant OPT-821 versus OPT-821 alone in metastatic sarcoma patients rendered disease-free by surgeryEvan Rosenbaum, Rashmi Chugh, Christopher W Ryan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 18, 2026
Atezolizumab for Alveolar Soft Part Sarcoma: A Clinical Trial UpdateAlice P Chen, Christina L Rosenberger, Nancy Moore, et al.
The New England Journal of Medicine|September 6, 2023
Atezolizumab for Advanced Alveolar Soft Part SarcomaAlice P Chen, Elad Sharon, Geraldine O'Sullivan-Coyne, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Scientific Reports|September 4, 2020
Dose-response assessment by quantitative MRI in a phase 1 clinical study of the anti-cancer vascular disrupting agent crolibulinAndres M Arias Lorza, Harshan Ravi, Rohit C Philip, et al.
Cancer|November 24, 2020
A randomized, open-label, phase 2, multicenter trial of gemcitabine with pazopanib or gemcitabine with docetaxel in patients with advanced soft-tissue sarcomaNeeta Somaiah, Brian Andrew Van Tine, Amy E Wahlquist, et al.
Neuro-Oncology|April 4, 2017
Timed sequential therapy of the selective T-type calcium channel blocker mibefradil and temozolomide in patients with recurrent high-grade gliomasMatthias Holdhoff, Xiaobu Ye, Jeffrey G Supko, et al.
Neuro-Oncology|August 8, 2018
Response assessment of meningioma: 1D, 2D, and volumetric criteria for treatment response and tumor progressionRaymond Y Huang, Prashin Unadkat, Wenya Linda Bi, et al.
European Journal of Cancer (Oxford, England : 1990)|October 10, 2022
A randomised phase II trial of a trivalent ganglioside vaccine targeting GM2, GD2 and GD3 combined with immunological adjuvant OPT-821 versus OPT-821 alone in metastatic sarcoma patients rendered disease-free by surgeryEvan Rosenbaum, Rashmi Chugh, Christopher W Ryan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 18, 2026
Atezolizumab for Alveolar Soft Part Sarcoma: A Clinical Trial UpdateAlice P Chen, Christina L Rosenberger, Nancy Moore, et al.
The New England Journal of Medicine|September 6, 2023
Atezolizumab for Advanced Alveolar Soft Part SarcomaAlice P Chen, Elad Sharon, Geraldine O'Sullivan-Coyne, et al.
Pageof 3